Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from randomised controlled trial
- 16 November 2002
- Vol. 325 (7373), 1135
- https://doi.org/10.1136/bmj.325.7373.1135
Abstract
Objective:To assess the cost effectiveness of ultrasound screening for abdominal aortic aneurysms. Design: Primary analysis: four year cost effectiveness analysis based directly on results from a randomised controlled trial in which patients were individually allocated to invitation to ultrasound screening (intervention) or to a control group not offered screening. Secondary analysis: projection of the data, based on conservative assumptions, to indicate likely cost effectiveness at 10 years. Setting:Four centres in the United Kingdom. Screening delivered in primary care settings with follow up and surgery offered in the main hospitals Participants: Population based sample of 67 800 men aged 65-74 years. Main outcome measures:Mortality from and costs (screening, follow up, elective and emergency surgery) related to abdominal aortic aneurysm; cost per life year gained. Results:Over four years there were 47 fewer deaths related to abdominal aortic aneurysms in the screening group than in the control group, but the additional costs incurred were £2.2m. After adjustment for censoring and discounted at 6% the mean additional cost of the screening programme was £63.39 ($97.77, €100.48) (95% confidence interval £53.31 to £73.48) per patient. The hazard ratio for abdominal aortic aneurysm was 0.58 (0.42 to 0.78). Over four years the mean incremental cost effectiveness ratio for screening was £28 400 (£15 000 to £146 000) per life year gained, equivalent to about £36 000 per quality adjusted life year. After 10 years this figure is estimated to fall to around £8000 per life year gained. Conclusions:Even at four years the cost effectiveness of screening for abdominal aortic aneurysms is at the margin of acceptability according to current NHS thresholds. Over a longer period the cost effectiveness will improve substantially, the predicted ratio at 10 years falling to around a quarter of the four year figure.Keywords
This publication has 19 references indexed in Scilit:
- The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trialThe Lancet, 2002
- Late results concerning feasibility and compliance from a randomized trial of ultrasonographic screening for abdominal aortic aneurysmBritish Journal of Surgery, 2002
- Hospital Costs and Benefits of Screening for Abdominal Aortic Aneurysms. Results from a Randomised Population Screening TrialEuropean Journal of Vascular and Endovascular Surgery, 2002
- Incremental net benefit in randomized clinical trialsStatistics in Medicine, 2001
- Analysis of cost data in randomized trials: an application of the non-parametric bootstrapStatistics in Medicine, 2000
- Health service costs and quality of life for early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysmsThe Lancet, 1998
- Long term relative survival after surgery for abdominal aortic aneurysm in Western Australia: population based studyBMJ, 1998
- Screening for abdominal aortic aneurysm: A computer assisted cost-utility analysisEuropean Journal of Vascular and Endovascular Surgery, 1996
- Costs, effects and C/E‐ratios alongside a clinical trialHealth Economics, 1994
- Screening for Abdominal Aortic Aneurysm in Men Ages 60 to 80 Years: A Cost-Effectiveness AnalysisAnnals of Internal Medicine, 1993